While 100% of the MMTV-Ras and over 90% of the MMTV-Neu transgenic mice in the wild-type Pin1 background developed one or several breast cancers within 75 weeks of observation, over 85% of transgenic mice in the Pin1 -/- background remained breast cancer-free over the same period. This evidence concerns the gene ERBB2 and breast cancer.